Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2015-06-09

FDA Approved: TRIMETHOBENZAMIDE HYDROCHLORIDE — Supplemental Application (Lupin Pharmaceuticals,Inc.)

View source ↗

Summary

The FDA approved Lupin Pharmaceuticals' supplemental application for trimethobenzamide hydrochloride. This action authorizes the changes described in the supple…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Trimethobenzamide hydrochloride (Trimethobenzamide hydrochloride)

Snippet

SUPPL AP for TRIMETHOBENZAMIDE HYDROCHLORIDE (TRIMETHOBENZAMIDE HYDROCHLORIDE)